Cargando…
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
PURPOSE: Recently, the Connective Tissue Oncology Society published consensus guidelines for recognizing ultrarare sarcomas (URS), defined as sarcomas with an incidence ≤1 per 1,000,000. We assessed the outcomes of 56 patients with soft tissue, and 21 with bone sarcomas, enrolled in Phase 1 trials....
Autores principales: | Moyers, Justin T., Pestana, Roberto Carmagnani, Roszik, Jason, Hong, David S., Naing, Aung, Fu, Siqing, Piha-Paul, Sarina, Yap, Timothy A., Karp, Daniel, Rodon, Jordi, Livingston, Andy, Zarzour, Maria Alejandra, Ravi, Vinod, Patel, Shreyaskumar, Benjamin, Robert S., Ludwig, Joseph, Herzog, Cynthia, Ratan, Ravin, Somaiah, Neeta, Conley, Anthony, Gorlick, Richard, Meric-Bernstam, Funda, Subbiah, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843435/ https://www.ncbi.nlm.nih.gov/pubmed/36288393 http://dx.doi.org/10.1158/1078-0432.CCR-22-2509 |
Ejemplares similares
-
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2023) -
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
por: Groisberg, Roman, et al.
Publicado: (2017) -
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors
por: Dembla, Vikas, et al.
Publicado: (2017) -
Jazz samba
Publicado: (1997) -
Using Samba
por: Ts, Jay, et al.
Publicado: (2003)